Locations:
Search IconSearch

Heart, Vascular and Thoracic

ACC-690×380

Novel Anticoagulation System Fails to Best Bivalirudin in Setting of PCI

Allergic reactions doom factor IXa inhibitor and antidote

AHA-690×380

The Best of AHA 2014

Leading cardiologist picks studies with most impact

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

PCSK9 Inhibitors

PCSK9 Inhibitors: With Likely Approval Imminent, What Should We Make of Them?

Unprecedented LDL-C reductions raise hopes for long-term outcome trials

Baylor-690×380

Cleveland Clinic Teams with Three Baylor Hospitals to Provide Heart Care

Systems will share clinical, academic and research components

Endarterectomy

Remote Endarterectomy Offers Hope for PVD Patients

The third pathway for arterial revascularization

TAVR-690×380

What You Should Know About TAVR

Here’s where this state-of-the-art treatment stands

BackPage 100 of 108Next

Advertisement

Ad